Hepatitis Quest Moves From C to B Under Former Gilead Executives
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc) CMRX US (Chimerix Inc) CTRV US (ContraVir Pharmaceuticals Inc) 1074952D US (OnCore Biopharma Inc)
People James Sapirstein (ContraVir Pharmaceuticals Inc) John Maraganore (Alnylam Pharmaceuticals Inc) M Berrey (Chimerix Inc) Michael J Yee (RBC Capital Markets) William Symonds (Gilead Pharmasset LLC)
Topics Viral Hepatitis
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283